Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Keryx Biopharm Inc (KERX)

4.56 -0.18 (-3.8%)

12-11 16:00

Open:

4.75

Pre. Close:

4.74

High:

4.82

Low:

4.55

Volume:

1,166,823

Market Cap:

544M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

4.92 - 5.01

5.01 - 5.11

Low:

4.23 - 4.36

4.36 - 4.5

Close:

4.4 - 4.55

4.55 - 4.72

Technical analysis  (as of: 2017-12-11 4:48:57 PM)

Overall:

      

Stoxline posted a BUY today, downgraded from strong buy. But this stock still is very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 6.70     One year: 7.71

Support:

Support1: 4.33    Support2: 3.60

Resistance:

Resistance1: 5.73    Resistance2: 6.60

Pivot:

4.72

Moving Averages:

MA(5): 4.59     MA(20): 4.76

MA(100): 6.40     MA(250): 6.18

MACD:

MACD(12,26): -0.30     Signal(12,26,9): -0.35

%K %D:

%K(14,3): 40.87     %D(3): 29.20

RSI:

RSI(14): 36.96

52-Week:

High: 8.38  Low: 4.33  Change(%): -20.4

Average Vol(K):

3-Month: 195684  10-Days 177389

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
KERX has closed above bottom band by 16.4%. Bollinger Bands are 63.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to KERX's normal range. The bands have been in this narrow range for 9 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 11 Dec 2017 16:30:00 GMT
Lookout for Price Target? Globalstar, Inc. (GSAT), Keryx Biopharmaceuticals ...

Mon, 11 Dec 2017 03:00:00 GMT
Keryx Biopharmaceuticals Inc Risk Points versus Health Care

Mon, 11 Dec 2017 13:18:45 GMT
Stock Volatility Risk Alert: Keryx Biopharmaceuticals Inc Stock Volatility ...

Mon, 11 Dec 2017 12:11:15 GMT
Dissecting the Investment Cases for BioCryst Pharmaceuticals, Inc. (BCRX) and ...

Tue, 14 Nov 2017 19:30:00 GMT
Keryx Biopharma Down 17% Despite Drug Approval

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

119.22

Shares Float (M)

82.30

% Held by Insiders

1.32

% Held by Institutions

68.88

Shares Short (K)

20250

Shares Short Prior Month (K)

16710

Stock Financials

EPS

-1.500

EPS Est. Current Year

-1.230

EPS Est. Next Year

-0.320

EPS Est. Next Quarter

-0.160

Forward EPS

-0.410

Book Value (p.s.)

0.080

PEG Ratio

-0.03

Profit Margin

Operating Margin

-203.11

Return on Assets (ttm)

-38.2

Return on Equity (ttm)

-1077.8

Qtrly Rev. Growth

136.6

Gross Profit (p.s.)

-0.073

Sales Per Share

EBITDA (p.s.)

-0.870

Qtrly Earnings Growth

Operating Cash Flow (M)

-93.67

Levered Free Cash Flow (M)

-32.12

atoplab.com

Valuation

P/E

-3.04

P/E Growth Ratio

-0.04

P/BV

57.00

P/S

1181832960.00

P/CF

-5.80

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.